Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV

Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infection in infants. Immunoprophylaxis with the anti-RSV monoclonal antibody, palivizumab, reduces the risk for RSV-related hospitalizations, but its use is restricted to high-risk infants due to the high cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomi, Rika, Sharma, Anurag, Wu, Wenzhu, Worgall, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466083/
https://www.ncbi.nlm.nih.gov/pubmed/30597977
http://dx.doi.org/10.3390/vaccines7010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466083/
https://www.ncbi.nlm.nih.gov/pubmed/30597977
http://dx.doi.org/10.3390/vaccines7010003

Ejemplares similares